CUSIP: 09077J107
What is CUSIP 09077J107?
CUSIP 09077J107 identifies BRDS - BRIDGEBIO PHARMA INC - COM in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Open recent reporting periods for CUSIP 09077J107:
As of 31 Dec 2025, 1 institutional investors reported holding 187 shares of BRIDGEBIO PHARMA INC - COM (BRDS).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 187 | $14,304 | $76.49 | 1 | |
| 2025 Q3 | 187 | $9,713 | $51.94 | 1 | |
| 2025 Q2 | 187 | $8,075 | +$8,075 | $43.18 | 1 |
| 2023 Q4 | 0 | $0 | -$1 | $76.49 | 0 |
| 2023 Q3 | 1 | $1 | -$1,076,837 | $1.00 | 1 |
| 2023 Q2 | 532,378 | $1,076,838 | -$58,041,698 | $2.04 | 3 |
| 2023 Q1 | 128,974,508 | $36,136,400 | -$5,624,109 | $0.28 | 77 |
| 2022 Q4 | 157,901,493 | $28,447,930 | +$1,059,192 | $0.18 | 70 |
| 2022 Q3 | 147,230,139 | $51,962,048 | -$311,706 | $0.35 | 76 |
| 2022 Q2 | 152,265,219 | $95,778,000 | -$25,111,319 | $0.44 | 77 |
| 2022 Q1 | 154,406,924 | $375,709,000 | +$16,823,799 | $2.45 | 77 |
| 2021 Q4 | 146,117,344 | $888,628,000 | +$455,234,000 | $6.17 | 53 |